AGH Stock Overview
Althea Group Holdings Limited manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Althea Group Holdings Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.032 |
52 Week High | AU$0.064 |
52 Week Low | AU$0.026 |
Beta | 1.5 |
1 Month Change | -5.88% |
3 Month Change | -17.95% |
1 Year Change | -34.69% |
3 Year Change | -93.54% |
5 Year Change | -91.90% |
Change since IPO | -94.29% |
Recent News & Updates
Recent updates
Investors Continue Waiting On Sidelines For Althea Group Holdings Limited (ASX:AGH)
Feb 23Althea Group Holdings Limited (ASX:AGH) Shares Fly 28% But Investors Aren't Buying For Growth
Apr 18We Think Althea Group Holdings (ASX:AGH) Needs To Drive Business Growth Carefully
Jul 11The Consensus EPS Estimates For Althea Group Holdings Limited (ASX:AGH) Just Fell A Lot
Feb 28Is Althea Group Holdings (ASX:AGH) In A Good Position To Invest In Growth?
Feb 25When Will Althea Group Holdings Limited (ASX:AGH) Become Profitable?
Mar 13Can You Imagine How Althea Group Holdings' (ASX:AGH) Shareholders Feel About The 28% Share Price Increase?
Feb 06What You Need To Know About Althea Group Holdings Limited's (ASX:AGH) Investor Composition
Dec 04Shareholder Returns
AGH | AU Pharmaceuticals | AU Market | |
---|---|---|---|
7D | 0% | 2.0% | 1.3% |
1Y | -34.7% | 42.7% | 11.5% |
Return vs Industry: AGH underperformed the Australian Pharmaceuticals industry which returned 42.7% over the past year.
Return vs Market: AGH underperformed the Australian Market which returned 11.5% over the past year.
Price Volatility
AGH volatility | |
---|---|
AGH Average Weekly Movement | 10.9% |
Pharmaceuticals Industry Average Movement | 11.2% |
Market Average Movement | 8.8% |
10% most volatile stocks in AU Market | 17.1% |
10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: AGH's share price has been volatile over the past 3 months.
Volatility Over Time: AGH's weekly volatility (11%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | n/a | Josh Fegan | https://altheagroupholdings.com |
Althea Group Holdings Limited manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland. It also offers a range of education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. In addition, the company provides formulation and manufacturing of recreational cannabis products, such as beverages, edibles, concentrates, and topicals; and owns and operates a private medical cannabis clinic network under the MyAccess Clinics name.
Althea Group Holdings Limited Fundamentals Summary
AGH fundamental statistics | |
---|---|
Market cap | AU$13.13m |
Earnings (TTM) | -AU$20.99m |
Revenue (TTM) | AU$28.67m |
0.5x
P/S Ratio-0.6x
P/E RatioIs AGH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AGH income statement (TTM) | |
---|---|
Revenue | AU$28.67m |
Cost of Revenue | AU$13.28m |
Gross Profit | AU$15.39m |
Other Expenses | AU$36.39m |
Earnings | -AU$20.99m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.051 |
Gross Margin | 53.68% |
Net Profit Margin | -73.22% |
Debt/Equity Ratio | 0% |
How did AGH perform over the long term?
See historical performance and comparison